Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Strides Pharma Science Ltd ( (IN:STAR) ) has issued an update.
Strides Pharma Science Limited has announced that its trading window for dealing in the company’s shares will be closed from January 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations, 2015 and the company’s own code of conduct. The window will remain shut until 48 hours after the announcement of its financial results for the quarter and nine months ended December 31, 2025, with the exact date of the board meeting to approve these results to be communicated later, reinforcing the company’s adherence to regulatory norms and governance standards for market-sensitive information.
More about Strides Pharma Science Ltd
Strides Pharma Science Limited is an Indian pharmaceutical company headquartered in Bengaluru and Navi Mumbai, operating in the pharmaceutical industry with a focus on manufacturing and marketing generic medicines. The company’s shares are listed on both BSE (Scrip Code: 532531) and NSE (Symbol: STAR), indicating its presence in India’s public capital markets.
Average Trading Volume: 33,964
Technical Sentiment Signal: Strong Buy
Current Market Cap: 85.8B INR
For a thorough assessment of STAR stock, go to TipRanks’ Stock Analysis page.